Accessibility Menu
Universe Pharmaceuticals Inc Stock Quote

Universe Pharmaceuticals Inc (NASDAQ: UPC)

$4.34
(22.9%)
+0.81
Price as of December 4, 2025, 10:39 a.m. ET

KEY DATA POINTS

Current Price
$4.30
Daily Change
(22.9%) +$0.81
Day's Range
$3.56 - $4.31
Previous Close
$3.53
Open
$3.84
Beta
-0.02
Volume
490,917
Average Volume
461,806
Market Cap
2M
Market Cap / Employee
$3.53M
52wk Range
$2.51 - $197.20
Revenue
-
Gross Margin
0.30%
Dividend Yield
N/A
EPS
$61,196.14
CAPs Rating
-
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Universe Pharmaceuticals Inc Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
UPC-95.63%N/AN/A-100%
S&P+13.22%+85.17%+13.11%+75%
Advertisement

Universe Pharmaceuticals Inc Company Info

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

News & Analysis

No results found

No news articles found for Universe Pharmaceuticals Inc.

Financial Health

General

No data available

No data available for this period.

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

No data available

No data available for this period.

Liabilities

No data available

No data available for this period.

Ratios

No data available

No data available for this period.

Cash Flow

No data available

No data available for this period.

Valuation

MetricYoY Change

No results found

No podcast episodes available.

No results found

No transcripts available.

Advertisement

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.